A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Clinical trial NCT05518253 · RECRUITING

Trial details

NCT number: NCT05518253
Sponsor: Weijia Fang, MD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Tumor Advanced Solid Tumor Renal Cell Carcinoma Ovarian Cancer Cervix Cancer

Start date: 2022-05-30
Primary completion: 2026-05-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.